Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Understand the principles behind zero based budgeting and how to translate them into a practical, repeatable process.
16,123 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
A focused look at contrarian investing: why a fund would build a million-commerce stake in a high-growth SaaS vendor ...
Investors chasing quantum headlines often overlook how a big subscription software player can deliver durable AI-and-...
When a stock leads the market after a big index move, investors pay attention. This piece explains why Argan stock to...
Looking for aggressive portfolio examples that balance growth and risk? This guide provides concrete allocations, ste...
Salesforce has long been a growth leader in cloud software, but recent performance has cooled. This guide dives into ...
When a chief executive sells stock after exercising options, investors often wonder if confidence underpins the move....
A major insider purchase often sparks questions about a stock's future. This breakdown examines what the 125,000-shar...
A risk disclosure in SpaceX’s pre-IPO paperwork flags space-based warfare threats to Starlink. As investors watch an ...
Investors watch WWDC 2026 with high expectations as Apple readies a major AI push. This preview outlines what’s at st...
When a global pharma giant drops $1 billion on a single tech, investors sit up. This move by Johnson Johnson Just Pai...
A real world scenario shows how payments intended for roofing and solar work can disappear. This guide explains how t...